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SUMMARY 
Patients with endogenous depression fulfilling Feighner's criteria were included in the trial. All had 
pretrial scores above 20 on Hamilton's depression rating scale. 
Drugs were divided into groups A and B- Group A comprised of placebo and d-amphetamine. It 
was found that all patients who improved with d-amphetamine also improved with tricyclics. Two who did 
not improve with d-amphetamine did not improve with tricyclics. 
With the introduction of new anti-
depressants and with different symptom 
complexes responding to different drugs, 
it is becoming increasingly difficult to choose 
the right anti-depressant for a particular 
patient. Various attempts have been made 
to find out predictors for response to anti-
depressants. Clinical, biochemical and 
pharmacological predictors have been 
Studied. Only a few studies of response 
prediction have appeared in the literature 
(Murphy et al., 1978). Low baseline urinary 
excretion of 3 MHPG in depressives have 
been associated with good response to d-
amphetamine (Fawcett et al., 1972) and 
to imipramine (Mass et al., 1972). The 
response with a one to two day trial of 
d-amphetamine has been noted to be a good 
predictor of response to imipramine and 
desipramine (Fawcett et al. 1971). 
Although d-amphetamine is known to 
be a central nervous system stimulant, 
there is a wide variation in individual res-
ponses (Lasagna efal, 1953, Tecce & Cole 
1974, von Kammen & Murphy, 1975). 
If a one to two day administration of d-
amphetamine can predict responses to anti-
depressants which may otherwise require 
a 3 to 6 week trial, a more rational psycho-
pharmacological approach to the treat-
ment of depression could result rather than 
present day trial and error (Klein and 
Davis, 1969). 
This study is an attempt to evaluate 
the usefulness of a three day trial of d-
amphetamine as a predictor for response to 
tricyclic antidepressants and also to find 
out whether there is selective prediction for 
imipramine and amitriptyline. 
MATERIAL AND METHOD 
Subjects : Initially 17 patients (14 males, 
and 3 females) with endogenous depres-
sion fulfilling criteria of Feighner et al. (1978) 
for primary depression, in addition, one of 
the following were included in the trial : 
(a) Family history of depression 
(b) History of previous attack of depres-
sion 
{c) Early morning insomnia 
(d) Diurnal variation of mood. 
All had scores above 20 on Hamilton 
Depression Rating Scale. None of them 
had been on any treatment prior to the 
trial. Their ages ranged from 22 to 52 
yrs. All were admitted as inpatients at 
NIMHANS, Bangalore. During the first 
two days of their stay they were given 
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placebo and investigated. Two of them 
showed remarkable improvement and were 
hence excluded from the study. One patient 
developed severe stereotype after starting 
on trial drug, and was excluded. Thus 14 
patients were taken for the study. 
Administration of drugs : 
Drugs were divided into Groups A and 
B. Group A comprised of placebo and 
d-amphetamine (7.5 mg per capsule). 
Group B comprised of imipramine and 
amitriptyline. Patients were initially started 
on Group A drugs for the first three days, 
in a double blind manner. They were 
given 1 cap. at 8 a.m. and one at 2 p.m. 
For the next four weeks Group B drugs 
were given (double-blind) with graded 
increase in dosage starring from 75 mg to 
225 mg. (1st week, 1 cap. h.s., 2nd week, 
2 h.s., 3rd and 4th weeks, 3 h.s.). 
Evaluation of Treatment : 
Patients were rated on Hamilton 
Depression Rating Scale at the beginning 
of the trial, on the 1st and 3rd day of Group 
A use, and 2 weeks and 4 weeks after be-
ginning Group B. Ratings on all occa-
sions were done between 9 and 10 a.m. 
Criteria for evaluating response : 
50% reduction from the initial score 
was considered as good response. In eva-
luating response to Group A, 50% reduc-
tion in partial score (4 items on Hamilton 
Depression Rating Scale HDRS com-
prising depressed mood, work and interest, 
retardation, agitation) was used. 
RESULTS 
Fisher's Exact Probability test was 
used for finding statistical significance. 
When Hamilton Depression Rating 
Scale was used to evaluate there was im-
provement in two of fourteen patients 
(Table 1). On the third day the same 
results were obtained. 
On evaluation with partial scoring, 
i.e., on four items of HDRS as already 
mentioned— 
(1) 1st day observation showed same 
results as with evaluation on all 
items of HDRS (Table 3). 
TABLE 1—Response to Group A as on 
H. D. R. S. 
Place- d-am- on Day 1 and 
bo pheta- Total Day 3 of use 
mine 
Improved .. .. 2 2 
Not improved 6 6 12 p=0.3077 
6 8 14 N.S. 
TABLE 2—Response to Group B as on 
H. D. R.S. 
Imipramine Amitriptyline Total 
Improved .. 5 i 10 
Not improved 2 2 4 
7 7 14 
TABLE 3—Response to Group A as evaluated 
with partial score on 1st day of use 
Placebo d-amphetamine Total 
Improved .. 2 2 
Not improved 6 6 12 
6 8 14 
TABLE 4-—Response to Group A as evaluated 
to partial scores on 3rd day of use 
Place- d-am-
bo pheta- Total 
mine 
Improved .. .. 6 6 p=0.009 
Not improved 6 2 8 Significant. 
6 8 14 
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(2) 3rd day observation showed improve-
ment in 6 out of 8 patients who had 
been given d-amphetamine. This 
was statistically significant as com-
pared to group A placebo (Table 
4). 
All patients who improved with d-
amphetamine also improved with tricyclics. 
The two who did not improve with d-
amphetamine did not improve with tri-
cyclics. (Table 5). 
TABLE 5—Chart showing response to Group A 
and Group B drugs 
Serial 
num-
ber 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
10. 
11. 
12. 
13. 
14. 
Placet 
N.I. 
— 
— 
N.I 
— 
N.I 
N.I. 
— 
N.I 
— 
— 
— 
— 
N.I 
Imipramine 
d-amphetamine or Amitri-
ptyline 
N.I. 
I 
N.I. 
I 
I 
I 
I 
I 
I 
I 
I 
I 
N.I. 
N.I. 
I 
N.I-
I 
I 
Note : I Improved 
NI Not improved 
DISCUSSION 
We found significant association, 
between response to d-amphetame and 
tricyclics when improvement was evaluated 
with partial scores. These results are 
consistent with the study of Fawcett and 
Siomopoulos (1971) and Von Kammen 
and Murphy (1978). Their studies also 
had limitations because of the small num-
ber of subjects. 
Amphetamines have been used in the 
treatment of depression although their effi-
cacy has not been consistently demonstrated. 
Amphetamine may have unpleasant side-
effects, irritability, loss of sleep which may 
make the assessment of anti-depressant effect 
more complex. 
This study shows the d-amphetamine 
can be used as a predictor for response to 
tricyclics. Selective prediction for imi-
pramine or amitriptyline was not seen. 
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